PT1135514E - Vectores de vaivém adenovirais com deleção em e1b - Google Patents

Vectores de vaivém adenovirais com deleção em e1b Download PDF

Info

Publication number
PT1135514E
PT1135514E PT00907050T PT00907050T PT1135514E PT 1135514 E PT1135514 E PT 1135514E PT 00907050 T PT00907050 T PT 00907050T PT 00907050 T PT00907050 T PT 00907050T PT 1135514 E PT1135514 E PT 1135514E
Authority
PT
Portugal
Prior art keywords
shuttle vectors
gene
deleted adenoviral
adenoviral shuttle
treatment
Prior art date
Application number
PT00907050T
Other languages
English (en)
Inventor
Julie Nye
Terry Hermiston
Original Assignee
Onyx Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharma Inc filed Critical Onyx Pharma Inc
Publication of PT1135514E publication Critical patent/PT1135514E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Image Generation (AREA)
  • Image Processing (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00907050T 1999-01-28 2000-01-26 Vectores de vaivém adenovirais com deleção em e1b PT1135514E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11781499P 1999-01-28 1999-01-28

Publications (1)

Publication Number Publication Date
PT1135514E true PT1135514E (pt) 2009-07-20

Family

ID=22374975

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00907050T PT1135514E (pt) 1999-01-28 2000-01-26 Vectores de vaivém adenovirais com deleção em e1b

Country Status (10)

Country Link
EP (1) EP1135514B1 (pt)
AT (1) ATE431421T1 (pt)
AU (1) AU772544B2 (pt)
CA (1) CA2360355A1 (pt)
CY (1) CY1109288T1 (pt)
DE (1) DE60042196D1 (pt)
DK (1) DK1135514T3 (pt)
ES (1) ES2325303T3 (pt)
PT (1) PT1135514E (pt)
WO (1) WO2000044922A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030086903A1 (en) 2001-11-02 2003-05-08 Genvec, Inc. Therapeutic regimen for treating cancer
CA2474777A1 (en) * 2002-02-01 2003-08-07 Transgene S.A. Adenoviral vectors for modulating the cellular activities associated with pods
KR101922539B1 (ko) 2009-03-02 2018-11-27 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 종양 선택적 e1a 및 e1b 돌연변이

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670488A (en) * 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
US5801029A (en) * 1993-02-16 1998-09-01 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5981275A (en) * 1997-04-14 1999-11-09 Genzyme Corporation Transgene expression system for increased persistence

Also Published As

Publication number Publication date
ES2325303T3 (es) 2009-09-01
ATE431421T1 (de) 2009-05-15
DK1135514T3 (da) 2009-09-07
EP1135514B1 (en) 2009-05-13
WO2000044922A1 (en) 2000-08-03
CY1109288T1 (el) 2014-07-02
EP1135514A1 (en) 2001-09-26
DE60042196D1 (de) 2009-06-25
CA2360355A1 (en) 2000-08-03
AU772544B2 (en) 2004-04-29
AU2861300A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
HU9601073D0 (en) Rekombinant adenoviral vector and methods of use
IL122120A (en) Recombinant mva virus containing a foreign gene inserted in a naturally occuring deletion within the genome
HUT72558A (en) Defective adenovirus vectors and use thereof in gene therapy
EP0710288A4 (en) ADENOVIRAL VECTORS FOR TREATMENT OF HEMOPHILIA
DE69731611D1 (de) Eine Zusammensetzung enthaltend eine Detergenz und einen ein Tumorsuppressorgen kodierenden, adenoviralen Vektor
EP0797436A4 (en) INNOVATIVE ADENOVIRAL VECTORS, PACKAGING CELL LINES, RECOMBINANT ADENOVIRUS AND METHOD
CA2161962A1 (en) Adenovirus vectors for gene therapy
MX9705937A (es) Procedimiento de preparacion de genoma de adenovirus recombinantes.
NZ508399A (en) Packaging cell lines for use in facilitating the development of high capacity adenoviral vectors
PT1135514E (pt) Vectores de vaivém adenovirais com deleção em e1b
EP1418948A4 (en) ADENOVIRAL REPLICATION VECTORS
DK1071805T3 (da) Adenovirusvektorer til sygdomsbehandling
MX9702078A (es) Adenovirus que comprenden dos genes terapeuticos: suicida e inmunoestimulante.
WO2000029573A3 (en) Adenoviral vectors
DK1224310T3 (da) Fremstilling af rekombinante adenovira og adenovirale banker
WO2000022136A3 (en) Recombinant e1a deleted adenoviral vectors
酒井佳夫 Gene therapy for hepatocellular carcinoma using two recombinant adenovirus vectors with α-fetoprotein promoter and Cre/lox P system
UA70909C2 (uk) Рекомбінантний аденовірусний вектор, фармацевтична композиція, що його містить, та набір для зменшення проліферації пухлинних клітин
MY119381A (en) Recombinant mva virus, and the use thereof
MY134484A (en) Recombinant mva virus, and the use thereof